Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Bronchial Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Lung Diseases; Lung Neoplasms; Neoplasms; Neoplasms by Site; Respiratory Tract Diseases; Respiratory Tract Neoplasms; Thoracic Neoplasms | Phase 3 | ClinicalTrials |
| Hodgkin Disease; Lymphoma | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Hepatocellular | Phase 2 | ClinicalTrials |
| Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Neoplasms, Squamous Cell | Phase 2 | ClinicalTrials |
| Uterine Cervical Neoplasms | Phase 2 | ClinicalTrials |
| Stomach Neoplasms | Phase 2 | ClinicalTrials |
| Esophageal Neoplasms | Phase 3 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | Phase 2 | ClinicalTrials |
| Breast Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 1 | ClinicalTrials |
| Breast Neoplasms; Gastrointestinal Neoplasms | Phase 1 | ClinicalTrials |
| Nasopharyngeal Carcinoma | Phase 1 | ClinicalTrials |
| Lung Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | Phase 2 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
| Lymphoma; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell | Phase 2 | ClinicalTrials |
| Digestive System Diseases; Digestive System Neoplasms; Esophageal Diseases; Esophageal Neoplasms; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Neoplasms | Phase 2 | ClinicalTrials |
| Bronchial Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Lung Diseases; Lung Neoplasms; Neoplasms; Respiratory Tract Diseases; Respiratory Tract Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma | Phase 2 | ClinicalTrials |
| Hodgkin Disease; Lymphoma | Phase 2 | ClinicalTrials |
| Esophageal Neoplasms | Phase 3 | ClinicalTrials |
| Stomach Neoplasms | Phase 3 | ClinicalTrials |
| Lung Neoplasms; Small Cell Lung Carcinoma | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Hepatocellular | Phase 2 | ClinicalTrials |
| Melanoma | Phase 1 | ClinicalTrials |
| Carcinoma; Carcinoma, Hepatocellular; Stomach Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Endometrial Neoplasms; Ovarian Neoplasms; Uterine Cervical Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma; Liver Neoplasms | Phase 2 | ClinicalTrials |
| Lymphoma; Lymphoma, B-Cell | Phase 1/Phase 2 | ClinicalTrials |
| Colorectal Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Hepatocellular | Phase 3 | ClinicalTrials |
| Carcinoma; Nasopharyngeal Carcinoma | Phase 2 | ClinicalTrials |
| Lung Neoplasms | Phase 3 | ClinicalTrials |
| Osteosarcoma | Phase 2 | ClinicalTrials |
CONTENTS